Rare diseases
Investigational molecules
Locations
Ulitsa Beli Drin 9, 8600 Yambol, Bulgaria
Medical Center Berbatov Ltd. in Yambol, Bulgaria specialises in clinical trials of conditions such as Obesity, Chronic kidney disease, Type 2 diabetes mellitus, Graves' disease, and other specialisations. This site conducts important research.
The medical center is at the forefront of diabetes research, focusing on innovative treatment strategies for Type 2 Diabetes (T2D). The center's research aims to enhance glycemic control in patients whose condition is inadequately managed with current therapies.
By exploring the efficacy of novel drug combinations and insulin regimens, the center contributes significantly to the development of more effective and patient-friendly diabetes management protocols.
Clinical trials currently enrolling participants at this site.
A Phase III Randomized Double‑Blind Study of Elecoglipron for Adults with Type 2 Diabetes on Insulin
BulgariaRandomized Phase III trial of elecoglipron plus dapagliflozin on kidney outcomes and mortality in adults with chronic kidney disease
BulgariaA Phase III Study of Elecoglipron Compared with Semaglutide for Adults with Type 2 Diabetes Mellitus
BulgariaLong‑term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity and Type 2 Diabetes
BulgariaPhase 3 Randomized Placebo‑Controlled Study of Efgartigimod Alfa in Adults with Graves’ Disease Inadequately Controlled by Antithyroid Drugs
BulgariaLong-Term Study of Imeroprubart in Adults With Graves' Disease
BulgariaA study to evaluate the effect of orforglipron on cardiovascular health in adults with atherosclerotic cardiovascular disease and/or chronic kidney disease
BulgariaStudy of IMVT-1402 Treatment for Adults with Graves' Disease
BulgariaA Phase III Study of Lenbelintide in Adults with Obesity or Overweight and Weight‑Related Comorbidity Without Type 2 Diabetes
BulgariaStudy of zenagamtide versus insulin glargine in adults with type 2 diabetes and high cardiovascular risk uncontrolled on oral medications
BulgariaKAI-9531 in Adults With Obesity or Overweight and Diabetes
BulgariaEfficacy and Safety of MET097 Once Weekly in People with Overweight or Obesity and Type 2 Diabetes
BulgariaMove up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.
See the offer for sitesTell us about your condition – we search every trial in Europe and connect you with the right site.
